Ming Hu Han

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders
    Ming Hu Han
    Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY, USA
    Neuropharmacology 62:89-100. 2012
  2. ncbi Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation
    Pamela J Kennedy
    Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
    Nat Neurosci 16:434-40. 2013
  3. ncbi Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
    Dipesh Chaudhury
    Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
    Nature 493:532-6. 2013
  4. ncbi HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
    Mitsumasa Kurita
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Nat Neurosci 15:1245-54. 2012

Collaborators

  • Scott J Russo
  • Javier Gonzalez-Maeso
  • Jian Feng
  • Mitra Heshmati
  • Ian Maze
  • Dipesh Chaudhury
  • Pamela J Kennedy
  • Eric J Nestler
  • Ezekiell Mouzon
  • Allyson K Friedman
  • Rachael L Neve
  • Mitsumasa Kurita
  • Alexander R Nectow
  • Deveroux Ferguson
  • Mary Kay Lobo
  • Ana Badimon
  • Mats Ekstrand
  • Karl Deisseroth
  • Diane M Damez-Werno
  • Eric N Olson
  • Rhonda Bassel-Duby
  • Ana Domingos
  • LISA POMERANZ
  • Barbara Juarez
  • A J Robison
  • Stephen J Haggarty
  • Stacy M Ku
  • Daniel J Christoffel
  • Hsing Chen Tsai
  • Jessica J Walsh
  • Jeffrey M Friedman
  • Ja Wook Koo
  • Michelle S Mazei-Robison
  • Joseph D Buxbaum
  • David M Dietz
  • Amelia L Gallitano
  • Aintzane García-Bea
  • Sam A Golden
  • Giuseppe Mocci
  • Nagahide Takahashi
  • Alexey Kozlenkov
  • James Hanks
  • Li Shen
  • J Javier Meana
  • Terrell Holloway
  • Adrienne Umali
  • Luis F Callado
  • Ane M Gabilondo
  • Jose L Moreno

Detail Information

Publications4

  1. ncbi Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders
    Ming Hu Han
    Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY, USA
    Neuropharmacology 62:89-100. 2012
    ..This article is part of a Special Issue entitled 'Anxiety and Depression'...
  2. ncbi Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation
    Pamela J Kennedy
    Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
    Nat Neurosci 16:434-40. 2013
    ..Our findings suggest a new mechanism by which prolonged and selective HDAC inhibition can alter behavioral and molecular adaptations to cocaine and inform the development of therapeutics for cocaine addiction...
  3. ncbi Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
    Dipesh Chaudhury
    Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
    Nature 493:532-6. 2013
    ..Overall, these studies reveal novel firing-pattern- and neural-circuit-specific mechanisms of depression...
  4. ncbi HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
    Mitsumasa Kurita
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Nat Neurosci 15:1245-54. 2012
    ..These observations support the view of HDAC2 as a promising new target for schizophrenia treatment...